SeerPharma is excited to be sponsoring BioMelbourne Network’s 8th Annual Device + Diagnostics Lab, to be held on Thursday the 5th of March.
This article was originally published by SeerPharma's business partner MasterControl and is republished in-part here with their permission.
INFOGRAPHIC: A snapshot of how SeerPharma supported its clients in 2019 on matters of Quality Assurance and GMP compliance.
SeerPharma’s training division grows from strength to strength with several companies requesting tailored on-site QA/GMP training for staff. Recently a major multinational pharmaceutical manufacturer approached SeerPharma to address the following key areas of interest for staff at their firm:
This article was originally published by the UTS Graduate School of Health is republished here with their permission.
Several pharmaceutical and medical device manufacturers in the Asia-Pacific region have approached and engaged SeerPharma for assistance on matters related to Computer System Validation (CSV). Typical requests have seen SeerPharma address computer systems validation approaches to meet the regulatory requirements of Annex 11 of the PIC/S Guide to...
This article was originally published by SeerPharma's business partner MasterControl and is republished in-part here with their permission.
SeerPharma is a consulting firm that has existed for over 30 years, assisting companies in the Asia-Pacific region conducting steps in manufacture of life-saving pharmaceuticals/medical devices on matters of Quality Assurance and GMP compliance. Quality impacts every step of manufacture from API to fill/finish for pharmaceuticals, design and...
SeerPharma exhibited and attended the International Society for Pharmaceutical Engineering (ISPE) inaugural South Asia Pharmaceutical Manufacturing conference in Bangalore, India from 25 to 27 September 2019.
The requirement to perform regular Product Quality Reviews (PQRs) is mandated in most codes of Good Manufacturing Practice. For most of these, the frequency of these reviews is to be at least annually.
